Homocysteine-induced cardiomyocyte apoptosis and plasma membrane flip-flop are independent of S-adenosylhomocysteine: a crucial role for nuclear p47(phox). by Sipkens, J.A. et al.
Homocysteine-induced cardiomyocyte apoptosis and plasma
membrane flip-flop are independent of S-adenosylhomocysteine:
a crucial role for nuclear p47phox
Jessica A. Sipkens • Paul A. J. Krijnen • Nynke E. Hahn • Melissa Wassink •
Christof Meischl • Desire´e E. C. Smith • Rene´ J. P. Musters • Coen D. A. Stehouwer •
Jan A. Rauwerda • Victor W. M. van Hinsbergh • Hans W. M. Niessen
Received: 13 January 2011 / Accepted: 28 June 2011 / Published online: 8 July 2011
 Springer Science+Business Media, LLC. 2011
Abstract We previously found that homocysteine (Hcy)
induced plasma membrane flip-flop, apoptosis, and necro-
sis in cardiomyocytes. Inactivation of flippase by Hcy
induced membrane flip-flop, while apoptosis was induced
via a NOX2-dependent mechanism. It has been suggested
that S-adenosylhomocysteine (SAH) is the main causative
factor in hyperhomocysteinemia (HHC)-induced patho-
genesis of cardiovascular disease. Therefore, we evaluated
whether the observed cytotoxic effect of Hcy in cardio-
myocytes is SAH dependent. Rat cardiomyoblasts (H9c2
cells) were treated under different conditions: (1) non-
treated control (1.5 nM intracellular SAH with 2.8 lM
extracellular L-Hcy), (2) incubation with 50 lM adenosine-
2,3-dialdehyde (ADA resulting in 83.5 nM intracellular
SAH, and 1.6 lM extracellular L-Hcy), (3) incubation with
2.5 mM D,L-Hcy (resulting in 68 nM intracellular SAH and
1513 lM extracellular L-Hcy) with or without 10 lM
reactive oxygen species (ROS)-inhibitor apocynin, and (4)
incubation with 100 nM, 10 lM, and 100 lM SAH. We
then determined the effect on annexin V/propodium iodide
positivity, flippase activity, caspase-3 activity, intracellular
NOX2 and p47phox expression and localization, and nuclear
ROS production. In contrast to Hcy, ADA did not induce
apoptosis, necrosis, or membrane flip-flop. Remarkably,
both ADA and Hcy induced a significant increase in
nuclear NOX2 expression. However, in contrast to ADA,
Hcy additionally induced nuclear p47phox expression,
increased nuclear ROS production, and inactivated flip-
pase. Incubation with SAH did not have an effect on cell
viability, nor on flippase activity, nor on nuclear NOX2-,
p47phox expression or nuclear ROS production. HHC-
induced membrane flip-flop and apoptosis in cardiomyo-
cytes is due to increased Hcy levels and not primarily
related to increased intracellular SAH, which plays a
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crucial role in nuclear p47phox translocation and subsequent
ROS production.
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Introduction
Hyperhomocysteinemia (HHC) as a risk factor for cardio-
vascular disease has been described in many in vivo and in
vitro studies. Patient and animal studies have shown a
positive correlation between increased homocysteine (Hcy)
levels with increased risk for cardiovascular complications
including endothelial dysfunction, atherosclerosis, and
myocardial infarction [1–3]. In vitro studies have proven
that Hcy causes proliferation of SMC [4, 5], but also oxi-
dative stress [6] and cell death in endothelial cells [7, 8].
Hcy is an amino acid of the methionine metabolism.
Methionine (Met) is converted into S-adenosylmethionine
(SAM), which is the main source of methyl for methylation
of DNA, RNA, and proteins [9]. Once the methylgroup is
transferred to methyltransferases, S-adenosylhomocysteine
(SAH) remains. SAH is subsequently hydrolyzed to Hcy
and adenosine (Fig. 1). Due to either genetic defects or
deficiencies in co-factors such as vitamin B6, B12, and
folate, accumulation of Hcy occurs [10]. An increase in
Hcy also results in an increase in SAH. SAH is known as a
potent inhibitor of methylation of DNA, RNA, and proteins
since it can bind to methyltransferases but cannot donate a
methylgroup necessary for methylation to occur [11].
Castro et al. [12] have demonstrated in endothelial cells
that increased SAH induced hypomethylation of DNA,
which may lead to inappropriate gene expression and
ultimately promotion of endothelial dysfunction. James
et al. [13] suggested that SAH-induced DNA
hypomethylation is the main causative factor for HHC-
induced cardiovascular pathogenesis. However, none of the
previous studies have given conclusive evidence that
increased SAH alone is the causative factor in Hcy-induced
cellular damage since these studies were performed in
conditions in which increased SAH was accompanied by
increased Hcy levels.
The NADPH-oxidase (NOX) complex was originally
found to be responsible for the generation of reactive
oxygen species (ROS) during the respiratory burst in
phagocytic cells, but it has become clear that NOX-derived
ROS are also involved in cellular signaling (so called
redox-signaling) in other cell types [14]. The NOX com-
plex subunits p22phox, gp91phox (NOX2), p67phox, and
p47phox have been identified in cardiomyocytes [15–17].
Previously, we have shown that Hcy induced apoptosis in
cardiomyocytes through a nuclear NOX2-mediated ROS
production mechanism and also induced membrane flip-
flop and necrosis [18]. In a subsequent study, we also
revealed that the induction of membrane flip-flop was due
to inactivation of flippase [19]. Taken together these find-
ings in part could explain the development of heart failure,
found in HHC patients [20]. However, whether Hcy is the
causative factor of the cardiomyocyte damage or the
increased SAH remains to be determined. This information
is important for future therapy development in heart failure
in patients with HHC, since it would provide a more
specified target for putative therapeutics. Therefore, in the
present study, we have analyzed the role of SAH in the
induction of membrane flip-flop, apoptosis, and necrosis in
cardiomyocytes.
Materials and methods
Cell cultures
Rat cardiomyoblasts (H9c2 (2-1) cells ATCC, Manassas,
VA, USA) were cultured in Dulbecco’s Modified Eagles
Medium (DMEM BioWhittaker, Verviers, Belgium) sup-
plemented with 10% heat-inactivated fetal calf serum (FCS
BioWhittaker), 2 mM L-glutamine (GIBCO, Paisley, UK),
100 IU/ml penicillin (Yamanouchi Europe BV, Leider-
dorp, Netherlands), and 100 lg/ml streptomycin (Radio-
pharma-Fisiopharma, Palomonte, Italy) and grown at 37C
in a humidified 5% CO2/95% air atmosphere. Experiments
were performed with cells grown to a confluency of
60–80%.
Antibodies and chemicals
Monoclonal antibody 48 against NOX2 IgG 1 (1:28) was
obtained from Sanquin Research at CLB, Amsterdam, The
Homocysteine
Methionine S-Adenosylmethionine (SAM)
S-Adenosylhomocysteine (SAH)
Adenosine
Methylation
CH3
Fig. 1 Homocysteine metabolism. Schematic representation of
methionine/homocysteine metabolism. Methionine (Met) is phospho-
rylized to S-Adenosylmethonine (SAM), a potent methyldonor for
methyltransferases. After donating the methylgroup, S-Adenosylho-
mocysteine (SAH) remains, which in turn is a potent inhibitor of
methylation. SAH is then hydrolyzed to homocysteine and adenosine
by S-Adenosylhomocysteine hydrolase (SAHH), which is a reversible
reaction and will favor SAH when concentration of Hcy is increased
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Netherlands [21]. Cy3-labeled goat-anti-rabbit-Ig (1:75)
(Alexa Fluor Leiden, Netherlands) was used as a secondary
antibody. Polyclonal a-Nitrotyrosine IgG (1:50) (Invitro-
gen, Eugene, OR, USA) was used as an antibody to mea-
sure nitrotyrosin residues, which is an indicator for ROS
production. In this case, Cy5-labeled goat-anti-rabbit-Ig
(1:50) (Jackson Immuno Research, West Grove, PA, USA)
was used as a secondary antibody. The same procedure was
followed for the immunofluorescent staining with goat
anti-p47phox antibody (1:50) (c-20 Santa Cruz Biotechnol-
ogy Inc, CA, USA) where we used Cy3-labeled donkey-
anti-goat-Ig (1:40) (Alexa Fluor 568, Invitrogen) as a
secondary antibody. Again, we co-stained for nitrotyrosine;
however, now we used FITC-labeled swine-anti-rabbit
(1:50) (DakoCytomation, Glostrup, Denmark) as a sec-
ondary antibody. Isotype controls and PBS were used to
determine aspecific binding.
Cells were incubated with either 2.5 mM D,L-Homo-
cysteine (Hcy), with 50 lM adenosine-2,3-dialdehyde
(ADA), with 100 nM, 10 lM, or 100 lM SAH or with
10 lM apocynin (all from Sigma, St. Louis, MO, USA) in
growth medium for 24 h at 37C in a humidified 5% CO2/
95% air atmosphere.
Measuring Hcy concentration in growth medium
Since we wanted to establish the effect of the inhibition of
SAH hydrolase by ADA on the effect of Hcy concentra-
tions, we determined the concentration of L-Hcy in culture
medium of the incubated H9c2 cells. To this day, it is not
possible to determine intracellular Hcy concentrations.
Extracellular L-Hcy was measured by the Abbott IMx
fluorescence polarization immunoassay (IMx Abbott Lab-
oratories, Abbott Park, IL, USA). Intra- and interassay CVs
were less than 2 and 4%, respectively. The concentration of
Hcy in culture medium was measured before incubation
(t = 0) and after 24 h of incubation.
Determination of intracellular S-adenosylmethionine
and S-adenosylhomocysteine
We determined the intracellular concentration of SAM and
SAH in H9c2 cells after 24 h of incubation with 2.5 mM
D,L-Hcy or 50 lM ADA. Liquid chromatography tandem
mass spectrometry (LC–MS/MS) was used for the deter-
mination of SAM/SAH concentrations as previously
described.
Flow cytometry
Phosphatidylserine exposure was assessed with FITC-
labeled human recombinant annexin V (Bender Med Sys-
tems, Vienna, Austria), while propidium iodide (PI Bender
Med Systems) was used to determine the permeability of
the cellular membrane.
After treatment, the cells were trypsinized and centri-
fuged at 4009g for 5 min at room temperature. Cells were
then washed with serum-free DMEM and resuspended in
serum-free DMEM containing annexin V (1:40) for 30 min
in the dark at 37C in a humidified 5% CO2/95% air
atmosphere. Shortly before measuring, PI was added to the
cell suspension (1:40). Cells were measured with a FAC-
SCalibur (Becton–Dickinson, San Jose, CA, USA). Results
were analyzed by Cell Quest Pro software (Becton–
Dickinson).
To determine flippase activity, cells were harvested after
incubation and resuspended in serum-free DMEM medium.
NBD labeled phosphatydylserine (PS-NBD: (1-palmitoyl-
2-(6-((7-nitro-2-1,3-benzoxadiazol-4-yl)amino)caproyl)-
sn-glycero-3-phosphoserine Avanti Polar Lipids, Alabas-
ter, AL, USA) was added in a final concentration of 1 lM
at 37C for 30 min to allow internalization of the probe by
flippase. Following, the cells were transferred to ice and
5 ml ice-cold PBS with BSA was added to wash off excess
probe attached to the outside of the cell membrane. After
15 min, the cells were pelleted and resuspended in serum-
free culture medium and then analyzed by flow cytometry
(FACSCalibur). With each experiment, part of the har-
vested cells was analyzed for Annexin V/PI positivity as
described before.
Determination of ATP levels
After treatment, cells were collected by trypsinization and
centrifugation at 4009g for 5 min. Cells were then counted
and equal amounts were taken per condition. After centri-
fugation for 2 min (4009g), the supernatant was discarded.
The pellet was resuspended in 150 ll of ice-cold perchloric
acid (PCA) 0.4 M. Cells were left on ice for 30 min and
then centrifuged again for 5 min (2,000g) at 4C. To the
isolated supernatant, 7.5 ll of K2CO3 5 M was added to
neutralize pH. Samples were subsequently stored at -80C
until measuring. The amount of ATP in the samples was
determined with a luciferase–luciferin assay (Biaffin GmbH
& Co KG, Kassel, Germany) according to the manufac-
turers’ protocol. Samples were measured in a FluoroNunc
MaxiSorp plate (Nalge Nunc International, Rochester, NY).
Luminescence was measured by using a Tecan GENios Plus
reader (Tecan Benelux, Mechelen, Belgium).
Detection of caspase-3 activity
Cells were grown in a 96-well plate (20,000 cells/well).
After treatment, cells were lysed and incubated with
DEVD-rhodamine 110 substrate (Roche, Mannheim, Ger-
many) for 1 h at 37C. Subsequently, the amount of free
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rhodamine was determined at a microplate fluorescence
reader (TECAN spectrafluor, Switzerland). The developed
fluorochrome was proportional to the concentration of
activated caspase-3 and could be quantified by a calibration
curve of diluted free rhodamine. Each condition was
measured in triplo per measurement (total of three
measurements).
Immunofluoresence microscopy
To measure the expression of NOX2, p47phox and the
putative formation of nitrotyrosine as an indirect mea-
surement of reactive oxygen species (ROS), cells were
incubated with or without 2.5 mM D,L-Hcy or 50 lM ADA
for 24 h in the 4-well chamber slides (Nalge Nunc Inter-
national). Cells were washed with PBS and fixated with 4%
formaldehyde for 10 min at 37C. Cells were subsequently
washed with PBS, permeabilized with acetone-methanol
(70–30%) for 10 min at -20C, and then washed again
with PBS/Tween-20 (0.05% (v/v) Tween-20 in PBS).
Subsequently cells were incubated with primary antibodies
for 60 min at room temperature followed by incubation
overnight at 4C. PBS and isotype controls were also tested
to determine nonspecific binding of the antibodies and
background signal. The following day, the cells were
washed with PBS/Tween and incubated with the secondary
antibodies for 30 min at room temperature. After sub-
sequent washes in PBS/Tween and PBS, the slides were
sealed in mounting medium containing DAPI (Vector
Laboratories Inc, Burlingame, CA, USA) to visualize
nuclei. Thereafter, the slides were covered with coverslips.
The generation of H2O2 was analyzed in live cells,
grown in Delta-T dishes (0.17 mm, clear; Bioptechs Inc.;
Butler, PA, USA). After treatment, the cells were loaded
with 10 lM 5-(6)-chloromethyl-20,70-dichlorodihydro-
fluorescein diacetate acetyl ester (CM-H2DCFDA; Molec-
ular Probes, Leiden) in ADS buffer (116 mM NaCl,
5.3 mM KCl, 1.2 mM MgSO4  7H2O, 1.13 mM NaH2-
PO4  H2O, 20 mM HEPES, and 1 mM CaCl2, pH 7.4) and
incubated for 15 min at 37C. The cells were then incu-
bated in ADS buffer for 25 min at 37C, allowing the
oxidized CM-H2DCFDA to accumulate in the cells.
All cells were analyzed by means of a 3I MarianasTM
digital imaging microscopy workstation (Zeiss Axiovert
200M inverted microscope Carl Zeiss, Sliedrecht, Nether-
lands), equipped with a nanostepper motor (Z-axis incr-
eaments 10 nm) and a cooled CCD camera (Cooke
Sensicam, 1280 9 1024 pixels Cooke Co, Tonawanda,
NY, USA). Visualization of NOX2 and nitrotyrosine was
performed with a 409 air lens. The microscope, camera,
and data viewing process were controlled by SlideBookTM
software (version 4.0.8.1 Intelligent Imaging Innovations,
Denver, CO, USA).
Statistics
Statistics were performed with the SPSS statistics program
(windows version 9.0). To evaluate whether observed dif-
ferences were significant, one-way ANOVA with Post-Hoc
Bonferroni tests was used. All values are expressed as
mean ± standard error of the mean (SEM). A P value (two
sided) of 0.05 or less was considered to be significant.
Results
Measurement of extracellular homocysteine,
intracellular S-adenosylhomocysteine concentration,
and intracellular SAM/SAH ratio
In the present study, we evaluated the role of SAH in the
homocysteine-induced decrease in cardiomyocyte viability.
First, we analyzed the intracellular concentrations of SAH
after incubation with either un-supplemented growth
medium, 2.5 mM D,L-Hcy or 50 lM ADA for 24 h. We
found that incubation of H9c2 cells with Hcy resulted in a
significant increase in SAH from 1.5 ± 0.8 nM in control
cells to 68 ± 2.2 nM in Hcy treated cells (Fig. 2b;
P \ 0.001, n = 4), while incubation with 50 lM ADA
resulted in an even higher significant increase to
83.5 ± 3.1 nM SAH compared to control and 2.5 mM D,L-
Hcy (both P \ 0.001, n = 4).
We next determined the extracellular L-Hcy concentra-
tion in culture medium after incubation with Hcy or ADA
for 24 h. Incubation with 2.5 mM D,L-Hcy resulted in a
significant increase of up to 1513 ± 10.2 lM L-Hcy in
medium (Fig. 2a; P \ 0.001, n = 4). Incubation with
50 lM ADA [22], however, did not result in an increase of
Hcy. In fact it resulted in a slight decrease to 1.6 ± 0.2 lM
L-Hcy compared to 2.8 ± 0.3 lM L-Hcy in control cells.
Information about the intracellular Hcy concentration
would have been a valuable addition to our current data.
However, we were unable to assess these levels since very
few laboratories are able to measure intracellular Hcy
concentrations [23].
In control cells, a high SAM/SAH ratio was found of
45.9 ± 2.7 (Fig. 2c) indicating the presence of more SAM
than SAH. In contrast, this ratio was significantly decreased
to 1.3 ± 0.1 in Hcy and ADA-treated cells (both
P \ 0.001). There was, however, no significant difference
in the SAM/SAH ratio between Hcy- and ADA-incubated
cells. This indicates that both incubations with Hcy or
ADA result in increased SAH levels and a decreased SAM/
SAH ratio. ADA, however, does not increase extracellular
Hcy concentrations, as expected, since it inhibits SAH
hydrolase thereby blocking Hcy formation [12].
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Effect of Hcy, ADA, and extracellular SAH on cell
viability
Previously, we have shown that incubation of H9c2 cells
with 2.5 mM Hcy during 24 h induced plasma membrane
flip-flop, apoptosis, and necrosis [18]. We now found that
whereas 2.5 mM Hcy did result in a significant decrease of
viable cells compared to the control cells, 50 lM ADA did
not result in a significant decrease, (Fig. 3a; P \ 0.001,
n = 20). Also, ADA did not induce an increases in single
annexin V-positive cells, nor in annexin V/PI-positive
cells, compared to control cells, whereas Hcy did (Fig. 3b
and c; P \ 0.001 and P \ 0.01, respectively). Finally, the
number of single PI-positive cells did not differ between
these three different groups (Fig. 3d). The effects of
extracellular SAH on H9c2 cell viability were also ana-
lyzed. Unlike Hcy, increasing concentrations of extracel-
lular SAH (100 nM, 10 lM and 100 lM) did not induce a
decrease in viability, nor an increase in annexin V and/or
PI positivity (Fig. 3a–d).
In line with this, ADA did not induce apoptosis as
measured via caspase-3 activity, whereas Hcy did induce a
significant increase of 77.7 ± 6.6% in caspase-3 activity
compared to control cells (Fig. 4a; P \ 0.001, n = 9).
In conclusion, unlike Hcy, ADA, as well as extracellular
SAH, did not induce membrane flip-flop, necrosis, and/or
apoptosis in cardiomyocytes.
Effect of Hcy, ADA, and extracellular SAH on flippase
activity
In a previous study, we found that Hcy induced membrane
flip-flop by inhibiting flippase activity in cardiomyocytes
[18]. Flippase is one of the membrane proteins, which has
been found to regulate transbilayer phospholipid asymmetry
in an ATP-dependent manner, by translocating phosphatidyl-
serine (PS) from the outer to the inner leaflet of the plasma
membrane [24]. We examined flippase activity via flow
cytometry analysis using a PS-NBD probe that is internalized
when flippase is active. As such the number of PS-NBD
negative cells is a measure for flippase inactivity. Treatment
with ADA or with extracellular SAH did not induce a sig-
nificant increase in PS-NBD negative cells compared to
control. Treatment with Hcy, however, did induce a signifi-
cant increase in PS-NBD negative cells compared to control,
ADA-incubated cells (Fig. 4c; 23.6 ± 3.6% (vs. control),
21.8 ± 3.0% (vs. ADA), 14.5 ± 2.1% (vs. SAH 100 nM),
23.6 ± 3.2% (vs. SAH 10 lM) and 18.5 ± 2.5% (vs. SAH
100 lM; P \ 0.001 (vs control and ADA), P \ 0.05 (vs.
SAH), n = 4). Therefore, in line with the cell viability
results, neither ADA nor extracellular SAH affected flippase
activity, whereas Hcy did.
Effect of ADA and Hcy on ATP levels
Since flippase is ATP dependent, we also determined ATP
levels in H9c2 cells after 24 h of incubation with either 50
lM ADA or 2.5 mM D,L-Hcy. We found that incubation
with ADA did not result in a decrease of ATP compared to
control. However, in concordance with our previous study,
we did find a significant decrease of 38.9 ± 9.3% in ATP
levels after incubation with Hcy (Fig. 4d; P \ 0.01).
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Fig. 2 Extracellular L-Homocysteine (Hcy) concentrations, intracel-
lular S-Adenosylhomocysteine (SAH) concentrations, and SAM/SAH
ratio. H9c2 cells were incubated with 2.5 mM D,L-Hcy or 50 lM
ADA during 24 h and a the extracellular L-Hcy was determined in
cultured medium of the different conditions, b the intracellular SAH
concentrations were determined, and c the SAM/SAH ratio as a
measure for methylation potential was determined. Data represent
mean ± SEM (n = 4)
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Effect of Hcy, ADA, and extracellular SAH on nuclear
NOX2 expression, ROS production, and p47phox
expression
Previously, we have also found that Hcy induced nuclear
NOX2 expression coinciding with nuclear ROS production
and apoptosis [18]. As we did not find an effect of ADA on
apoptosis induction, we analyzed whether this could be
explained by a lack of nuclear NOX2 translocation.
Hcy induced a significant increase of 42.2 ± 7.3% in
nuclear NOX2 expression compared to control cells
(Fig. 5a; P \ 0.05; n = 4; Fig. 6I, II). Remarkably, also
ADA resulted in a significant increase of nuclear NOX2
levels when compared to control cells (Fig. 5a;
113.1 ± 14.0%; P \ 0.001). This increase was even sig-
nificantly higher (70.9 ± 8.4%) than in Hcy treated cells
(Fig. 5a; P \ 0.001, n = 4; Fig. 6III). Notwithstanding
this, ADA did not induce nuclear ROS production, as
measured with nitrotyrosin and the generation of H2O2.
This might explain the lack of apoptosis induction by
ADA, while we did find a significant increase of nuclear
ROS in H9c2 cells incubated with Hcy compared to control
cells (Fig. 5b, g; P \ 0.001, 26.2 ± 4.7% for nuclear
tyrosine and 421.9 ± 17.4% for H2O2; n = 4; Fig. 6IV–
VI). Extracellular SAH did not induce increased nuclear
NOX2 expression (Fig. 5d), nor nuclear ROS (Fig. 5e, g).
Inhibition of ROS with apopcynin did induce a signifi-
cant decrease (76.0 ± 5.2%) of Hcy-induced caspase-3
activity (Fig. 4b; P \ 0.01, n = 6), although the Hcy-
induced active caspase-3 levels in the presence of apocynin
were still significantly higher (69.0 ± 12.7%) than those in
control cells (P \ 0.001). These results indicate that ROS
are necessary, at least in part, for Hcy-induced apoptosis.
Theoretically, the lack of ROS production, notwith-
standing increased nuclear NOX2 expression in ADA-
treated cells, could be related to a lack of nuclear p47phox
expression, which is a crucial non-catalytic subunit, in
induction of apoptosis, also in cardiomyocytes [25]. For
this, we performed 3D confocal stackings to acquire optical
sections of the cells to determine the exact intracellular
location of p47phox. We then found that Hcy induced
cytosolic and more importantly, nuclear p47phox expression
(Fig. 5c; 203.4 ± 15.9%, P \ 0.001, n = 4 and Fig. 6-
VIII) that was virtually absent in control cells (Fig. 6VII).
In contrast, no increased nuclear p47phox expression was
found in ADA-treated cells (Figs. 5c, 6VIIII) nor in
extracellular SAH-treated cells (Fig. 5f). From this, we can
conclude that albeit an induction of nuclear NOX2
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Fig. 3 Effects of Hcy, ADA, and extracellular SAH on cell viability.
a–d Flow cytometry analysis of H9c2 cells incubated with 2.5 mM
D,L-Hcy, 50 lM ADA or SAH (100 nM, 10 lM and 100 lM) for
24 h. A total of 10,000 cells were measured per sample (n = 20).
a Percentage of viable cells, which are annexin V and propidium
iodide (PI) negative. b Percentage of single annexin V-positive, PI-
negative labeled cells, which is a marker of flip-flop of the plasma
membrane phospholipids (reversible flip-flopped or apoptotic). c Per-
centage of double-annexin V/PI-positive cells depicting late apoptotic
and/or necrotic cells. d Percentage of single PI-positive cells, as a
measure of necrotic cells. All data represent mean percent-
ages ± standard error of the mean (SEM)
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expression was found, activation of the active NOX2
complex in cardiomyocytes is prohibited during ADA
incubation, probably related to a lack of nuclear p47phox
expression, as such preventing nuclear ROS production and
eventually apoptosis.
Discussion
It has been suggested that SAH rather than Hcy is the
culprit in HHC-induced cardiovascular pathogenesis [13].
In a previous study, we found that increased Hcy resulted
in membrane flip-flop, apoptosis, and necrosis of cardio-
myocytes [18]. Incubation of cardiomyocytes with Hcy
will, in addition to an increase in Hcy levels, also result in
an increase of intracellular SAH levels. In the present
study, we therefore analyzed the effect of ADA, a known
SAH hydrolase inhibitor, which solely increases intracel-
lular SAH since Hcy formation is blocked (see Fig. 2) [12]
and the effect of extracellular SAH. In accordance with our
previous study, we found that Hcy incubation resulted in
membrane flip-flop (due to inhibition of flippase
inactivity), induction of necrosis, a decrease in ATP levels,
and induction of apoptosis due to nuclear NOX2/p47phox-
mediated ROS production. Remarkably, none of these Hcy
effects were induced by ADA, except for induction of
nuclear NOX2 expression. However, in cells incubated
with ADA, the lack of nuclear p47phox expression appar-
ently prohibited nuclear ROS production and also no
inhibition of flippase activity was found. Remarkably, the
increase in nuclear NOX2 expression due to incubation
with ADA was approximately twice as much as after
incubation with Hcy. This could suggest that in response to
the lack of p47phox translocation to the nucleus by ADA,
the cells react by increasing nuclear NOX2 expression.
Like ADA, incubation with SAH did not have an effect on
cell viability, nor on flippase activity, nor on nuclear
p47phox expression or nuclear ROS production. However,
unlike ADA, SAH had no effect on nuclear NOX2
expression. This absence of effects may suggest that
extracellular SAH does not enter the cells. Indeed, recently
culturing of lymphoblasts in the presence of SAH (up to
25 lM) did not lead to increased intracellular SAH levels
(unpublished results of our laboratory).
A B
C D
p<0.001
p<0.001
p<0.001 p<0.01
p<0.01
control ADA Hcy 100 nM 10µM 100µM 
0
10
20
30
40
SAH
%
 o
f f
lip
pa
se
 in
ac
tiv
e 
ce
lls
(P
S 
ne
ga
tiv
e c
ell
s)
p<0.001 p<0.05
Control ADA Hcy
0
25
50
75
100
%
 in
cr
ea
se
 in
 c
as
pa
se
-3
ac
tiv
ity
 (v
s c
on
tro
l)
Control ADA Hcy
0
25
50
75
100
125
%
 d
ec
re
as
e 
in
 A
TP
 le
ve
ls
(co
nt
ro
l s
et 
to
 10
0%
)
Control Hcy Hcy
0
20
40
60
80
100
120
140
160
180
+
apocynin
%
 in
cr
ea
se
 in
 c
as
pa
se
-3
ac
tiv
ity
 (v
s c
on
tro
l)
Fig. 4 Effects of Hcy, ADA, and extracellular SAH on caspase-3
activity, flippase activity, and ATP levels. a, b Caspase-3 activity in
H9c2 cells that were incubated with 2.5 mM D,L-Hcy with or without
10 lM apocynin or with 50 lM ADA (n = 9). Caspase-3 activity
was measured as indicated under ‘‘Materials and methods’’ section.
c Flow cytometry analysis of flippase activity in H9c2 cells incubated
with 2.5 mM D,L-Hcy, with 50 lM ADA, or with SAH (100 nM,
10 lM, and 100 lM) for 24 h using NBD labeled PS. PS-NBD
negative cells represent cells where flippase is inactive since PS-NBD
is no longer internalized. Percentage of PS negative cells is shown.
d ATP levels in H9c2 cells that were incubated during 24 h with
2.5 mM D,L-Hcy or with 50 lM ADA (n = 8). ATP levels were
measured as indicated under ‘‘Materials and methods’’ section. All
data represent mean percentages ± SEM
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Fig. 5 Quantification of the nuclear expression of NOX2, p47phox,
and nitrotyrosine under Hcy, ADA, and extracellular SAH. H9c2 cells
were treated with either 2.5 mM D,L-Hcy, 50 lM ADA or SAH
(100 nM, 10 lM, and 100 lM) for 24 h, and the subcellular
expression of NOX2, p47phox, and nitrotyrosine was quantified using
digital imaging microscopy. a and d Nuclear localization of NOX2
expression. b and e Nuclear localization of nitrotyrosine. c and
f Nuclear localization of p47phox. g Nuclear generation of H2O2. Data
represent mean ± SEM (n = 4)
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Previous studies, unrelated to Hcy, have shown in
cardiomyocytes and hepatocytes that p47phox is a crucial
subunit in the active ROS-producing NOX complex. Qin
et al. [26] have shown that Angiotensin II induced apop-
tosis in H9c2 cells via an increase in cytoplasmic and
apparent nuclear p47phox expression as determined by
western blot and immunocytochemistry, which resulted in
intracellular ROS production; however, the effect on other
subunits such as NOX2 was not determined. Reinehr et al.
[27] have shown in p47phox knock-out mice that hepato-
cytes no longer produced ROS. Furthermore, Heymes et al.
[28] found an increase in translocation of p47phox to the
sarcolemmal membrane of cardiomyocytes in failing
human hearts compared to non-failing hearts, which coin-
cided with increased membrane and intracellular gp91phox
expression, analyzed by immunohistochemistry, which
could suggest that both p47phox and gp91phox are necessary
for cardiomyocyte damage. Heymes et al. did not, how-
ever, examine nuclear expression patterns as we did in the
present study, in which we show that Hcy induced an
increase in nuclear expression of both NOX2 and p47phox
which coincided with apoptosis of the cardiomyocyte.
The function and location of the several subunits of the
NOX complex have been studied extensively in polymor-
phonuclear neutrophils (PMNs). In PMNs, gp91phox
(NOX2) is located in the plasma membrane and during
activation p47phox translocates from the cytosol to the
membrane to form a complex with NOX2 [29]. For an
active NOX complex to occur, both NOX2 and p47phox
have to be phosphorylated, and in neutrophils, it has
already been established that NOX2 is phosphorylated by
protein kinase C (PKC) [30]. It has been shown that Hcy
induces activation of PKC and as such activates the NOX
complex in neutrophils by translocation of p47phox and
p67phox to the plasma membrane [31, 32]. However, until
now, no studies have shown PKC activation through SAH.
Albeit ADA, in contrast to Hcy, did not decrease ATP
levels, a lack of phosphorylation potential is unlikely to be
the explanation for the lack of NOX activation by ADA.
The actual effect of ADA on the phosphorylation level of
p47phox is now subject of further study.
We have previously found in cardiomyocytes that Hcy
induced membrane flip-flop was in part due to inactivation
of flippase [18]. In the present study, we have shown that
Control Hcy ADA
VII VIII VIIII
p47phox
IV V VI
nitrotyrosine
merge
I II III
X XI XII
NOX2
Fig. 6 Nuclear expression of NOX2, p47phox, and nitrotyrosine under
Hcy, and ADA. H9c2 cells were treated with either 2.5 mM D,L-Hcy
or 50 lM ADA for 24 h and analyzed for the subcellular expression
of NOX2, p47phox, and nitrotyrosine using digital imaging micros-
copy. Images I, II, III NOX2 expression (red); Images IV, V, VI
nitrotyrosine expression (green) as a marker for ROS production;
Images VII, VIII, VIIII p47phox expression (red); Images X, XI, XII
merged images of p47phox (red) and nitrotyrosine (green). In all
images DAPI staining (blue) for DNA (nuclei) is shown. Magnifica-
tion 409. (Color figure online)
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this membrane flip-flop is not related to an increase in SAH
alone, since incubation with ADA did not result in a
decrease in flippase activity.
The concentration of Hcy used in the current study is
higher than physiologically occur in humans. However, in
our previous study, we have already shown that Hcy con-
centration in growth medium decreased significantly dur-
ing 24 h incubation. Furthermore, short-term exposure to
high Hcy concentrations may reflect a prolonged exposure
to moderately elevated Hcy concentrations as occur life-
long in patients. The SAH concentrations that we measured
after incubation with ADA and Hcy, however, are com-
parable to the concentrations found intracellular in eryth-
rocytes of cardiovascular patients [33]. Another limitation
of the present study is that it was not possible to determine
the intracellular concentration of Hcy since very few lab-
oratories are able to measure this. Therefore, we cannot
state that incubation with ADA does not result in increased
intracellular Hcy levels. However, it is not expected that
ADA increases Hcy since it inhibits SAH hydrolase
thereby blocking Hcy formation [12].
Increased levels of Hcy as a risk factor for cardiovas-
cular disease and especially heart failure have been
described by several studies [20, 34]. There is an ongoing
debate, however, on whether increased Hcy or its related
increased SAH is the causative factor in cardiovascular
disease. It has been postulated that increased SAH is the
main causative factor since it induces hypomethylation of
DNA, RNA, and proteins, which could act as a possible
disease mechanism [35]. However, these previous studies
do not provide conclusive evidence that increased SAH
alone is the causative factor in Hcy-induced cellular
damage, since conclusions were drawn when increased
Hcy levels in patients were also present. In the present in
vitro study in cardiomyocytes, we have elucidated that
membrane flip-flop, apoptosis, and necrosis only occur
after incubation with Hcy, with coinciding increased levels
of Hcy and SAH, but not by increased SAH levels alone.
This is probably due to a lack of p47phox translocation by
SAH, preventing an active ROS-producing NOX complex.
Furthermore, increased SAH alone did not inhibit flippase
activity, prohibiting membrane flip-flop, while Hcy did.
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